ANN ARBOR, Mich., Feb. 08, 2021 (GLOBE NEWSWIRE) — Zomedica Corp. (NYSE American: ZOM), (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 91,315,790 common shares of Zomedica, at a price to the public of $1.90 per share, less underwriting… Source link
Read More »Penny stock Zomedica jumps 250% after someone paid Netflix star Carole Baskin $299 for a mention
TipRanks 3 “Strong Buy” Stocks with Over 9% Dividend Yield Markets ended 2020 on a high note, and have started 2021 on a bullish trajectory. All three major indexes have recently surged to all-time highs as investors seemingly looked beyond the pandemic and hoped for signs of a rapid recovery. Veteran strategist Edward Yardeni sees the economic recovery bringing its own slowdown with it. As the COVID vaccination program allows for further economic opening, with more people getting back to… Source link
Read More »